Thursday, January 6, 2022

< + > An Interview With The Team Leader For The Scientific Discovery Of Pfizer’s COVID-19 Drug, Paxlovid

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Canadian Healthcare Humor – Fun Friday

Happy Friday everyone!  You made it through another week.  We hope you had an amazing week and you’re ready for a great weekend.  If it’s Fr...